(Q34170420)

31 July 2017

title

Affinity of cyamemazine, an anxiolytic antipsychotic drug, for human recombinant dopamine vs. serotonin receptor subtypes (English)

1 reference

31 July 2017

0 references

Ahcène Hameg

1

1 reference

31 July 2017

Franck Bayle

2

1 reference

31 July 2017

Philippe Nuss

3

1 reference

31 July 2017

Philippe Dupuis

4

1 reference

31 July 2017

Ricardo P Garay

5

1 reference

31 July 2017

Michel Dib

6

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 February 2003

1 reference

31 July 2017

published in

Biochemical Pharmacology

1 reference

31 July 2017

volume

65

1 reference

31 July 2017

issue

3

1 reference

31 July 2017

page(s)

435-440

1 reference

5-HT3- and 5-HT2C-antagonist properties of cyamemazine: significance for its clinical anxiolytic activity

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901515-0

Cyamemazine as an anxiolytic drug on the elevated plus maze and light/dark paradigm in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901515-0

Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901515-0

Cloning and expression of human and rat D1 dopamine receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901515-0

Cloning of the cDNA and gene for a human D2 dopamine receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901515-0

Characterization of the human dopamine D3 receptor expressed in transfected cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901515-0

Multiple dopamine D4 receptor variants in the human population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901515-0

The pharmacology and distribution of human 5‐hydroxytryptamine2B (5‐HT2b) receptor gene products: comparison with 5‐HT2a and 5‐HT2c receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901515-0

Characterization of a human 5-hydroxytryptamine3 receptor type A (h5-HT3R-AS) subunit stably expressed in HEK 293 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901515-0

Use of 3H-muscimol for GABA receptor studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901515-0

Characteristics of GABAB receptor binding sites on rat whole brain synaptic membranes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901515-0

Heterogeneity of [3H]-mepyramine binding sites in guinea pig cerebellum and lung.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901515-0

Reversible and irreversible labeling and autoradiographic localization of the cerebral histamine H2 receptor using [125I]iodinated probes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901515-0

Histamine H3 receptor binding sites in rat brain membranes: modulations by guanine nucleotides and divalent cations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901515-0

Binding characteristics of 3H-prazosin to rat brain α-adrenergic receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901515-0

Rat spinal cord alpha 2-adrenoceptors are of the alpha 2A-subtype: comparison with alpha 2A- and alpha 2B-adrenoceptors in rat spleen, cerebral cortex and kidney using 3H-RX821002 ligand binding.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901515-0

Action of atypical antipsychotics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901515-0

The role of serotonin in antipsychotic drug action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901515-0

The influence of ritanserin, a serotonin antagonist, in anxiety disorders: a double-blind placebo-controlled study versus lorazepam

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901515-0

A comparative study of the effects of selective and non-selective 5-HT2 receptor subtype antagonists in rat and mouse models of anxiety.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901515-0

Biarylcarbamoylindolines are novel and selective 5-HT(2C) receptor inverse agonists: identification of 5-methyl-1-[[2-[(2-methyl-3-pyridyl)oxy]- 5-pyridyl]carbamoyl]-6-trifluoromethylindoline (SB-243213) as a potential antidepressant/anxiolytic agent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901515-0

Influence of the 5-HT2C receptor antagonist, SB-242084, in tests of anxiety

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901515-0

Effects of RO 60 0175, a 5-HT(2C) receptor agonist, in three animal models of anxiety.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901515-0

Molecular, pharmacological and functional diversity of 5-HT receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901515-0

Effect of low doses of clozapine on behaviour of isolated and group-housed male mice in the elevated plus-maze test

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901515-0

Comparison of the new atypical antipsychotics olanzapine and ICI 204,636 with clozapine on behavioural responses to the selective "D1-like" dopamine receptor agonist A 68930 and selective "D2-like" agonist RU 24213

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901515-0

Is clozapine an (partial) agonist at both dopamine D1 and D2 receptors?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901515-0

Sedative effects of the dopamine D1 receptor agonist A 68930 on rat open-field behavior

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901515-0

10.1016/S0006-2952(02)01515-0

7 January 2021

Identifiers

DOI

1 reference

31 July 2017

1 reference